Reyes Medina Bernardo, Wrede Arne, Schulz-Schaeffer Walter J
Institut für Neuropathologie, Medizinische Fakultät, Universität des Saarlandes und Universitätsklinikum des Saarlandes, Kirrberger Str. 100, Gebäude 90.3, 66421, Homburg, Deutschland.
Radiologie (Heidelb). 2023 Aug;63(8):577-582. doi: 10.1007/s00117-023-01171-2. Epub 2023 Jul 21.
Already with the update of the 4th edition of the World Health Organization (WHO) classification of tumors of the central nervous system, it was pointed out that pediatric diffuse glioma do not follow the same molecular mechanisms used to characterize adult diffuse glioma.
What changes result from the update of the classification of tumors of the central nervous system?
With the 5th edition of the WHO classification of tumors of the central nervous system, a second level of information containing molecular changes besides the histological characterization and grading of tumors was established.
A new classification of diffuse pediatric brain tumors based on molecular tumor pathways was established. The most important tumor pathways, considered for the new classification, were the activation of receptor tyrosine kinases and histone H3 alterations that cause epigenetic changes.
Increasingly better understanding of mechanisms in the development of pediatric brain tumors gives hope for more specific therapeutic approaches.
早在世界卫生组织(WHO)中枢神经系统肿瘤分类第4版更新时就已指出,儿童弥漫性胶质瘤并不遵循用于表征成人弥漫性胶质瘤的相同分子机制。
中枢神经系统肿瘤分类的更新带来了哪些变化?
随着WHO中枢神经系统肿瘤分类第5版的发布,除了肿瘤的组织学特征和分级外,还建立了包含分子变化的二级信息。
基于分子肿瘤通路建立了儿童弥漫性脑肿瘤的新分类。新分类所考虑的最重要的肿瘤通路是受体酪氨酸激酶的激活和导致表观遗传变化的组蛋白H3改变。
对儿童脑肿瘤发生机制的理解日益深入,为更具针对性的治疗方法带来了希望。